Participate in a Clinical Trial
Participating in a clinical trial is a great way to contribute to curing, preventing, and treating type 1 diabetes (T1D) and its complications. There are many opportunities in the Greater Western Carolinas area to participate in a T1D clinical trial close to home. See below for active opportunities.
Choosing to participate in a T1D clinical trial is a very personal decision, but one that can have a significant impact on curing, preventing and treating T1D. There are many opportunities in the Greater Western Carolinas area to participate in a T1D clinical trial close to home. See below for active opportunities.
Additionally, Breakthrough T1D has an easy-to-use tool called the Clinical Trials Connection where you can match with a clinical trial in 60 seconds. It asks users some simple questions about themselves before matching them with trials for which they are eligible. Clinical Trials Connection uses your city, distance you’re willing to travel and other characteristics to narrow down hundreds of trials to the ones in which you might be interested. Start your search by visiting breakthrought1d.org/impact/research/clinical-trials today!
If you have any questions, please contact our North Carolina Clinical Trials Education Volunteers Natasha Bolick or Thomas Kern.
Featured T1D Studies in Greater Western Carolinas
North Carolina
Developing of the Resilient, Empowered, Active Living with Diabetes for Families (REAL-Fam)
Researchers are seeking caregivers of children with type 1 diabetes, those living with type 1 diabetes, and healthcare providers to participate in a 60-90 minute virtual focus group. Participants will receive a $25 gift card. If interested, fill out the general interest form. Email Dr. Vanessa Jewell with any questions at vanessa_jewell@med.unc.edu.
https://www.med.unc.edu/healthsciences/diabetes
CureGN Diabetes
CureGN is a large multi-center, long-term study of patients with diabetes and who also have nephrotic syndrome or other glomerular diseases. The goal of the study is learn more about how diabetes can effect kidney disease.
Able to participate:
- Diabetes (Type 1 or Type 2)
- One of these glomerular (kidney) diseases: Minimal Change Disease (MCD), Focal Segmental Glomerulosclerosis (FSGS), Membranous Nephropathy (MN) , IgA Nephropathy (IgAN)
- At least 18 years old
- https://researchforme.unc.edu/index.php/en/study-details?rcid=3282
Virtual
UP-CBT (Telemedicine-Delivered Unified Protocol for Cognitive Behavioral Therapy for Anxiety and Depression
This study is recruiting participants aged 18-35 living with T1D for > 6 months, A1C 7.5-14%, with anxiety or depressive mood disorder. This project will evaluate a telemedicine-delivered, Unified Protocol for Cognitive-Behavioral Therapy (UPCBT) enhanced with continuous glucose monitor (CGM) review to target anxiety and depressive symptoms and glycemic control in young adults with type 1 diabetes.
- Age: 18-35
- Contact: Dr. Todd Farchione at tfarchio@bu.edu
The Effect of Gratitude Journaling on Psychological and Glycemic Outcomes in Adolescents with Type 1 Diabetes
Complete an 8-week study of gratitude journaling and surveys prior to and after finishing the gratitude journaling intervention. Study activities should take approximately 4 hours over 8 weeks to complete. Participants will be compensated $50 for completing the study. Eligibility requirements are adolescents between 12-17 years old with type 1 diabetes for at least 6 months, able to speak/read English, and access to the Internet.
Contact: Dr. Rebecca Koerner at rkoerner1@usf.edu
Resources
What Are Clinical Trials Video
Match To Clinical Trials in 60 Seconds
Breakthrough T1D and Clinical Trials
Meet Your CTEVs: Natasha Bolick
Natasha Bolick is a longtime supporter of Breakthrough T1D (formerly JDRF). She is very familiar with the hardships of T1D’s; her mom, sister, and grandmother were all T1D. Everyone in the house knew how to give shots, check glucose levels, and where the sugar was stored in the event of a low. Her family inspired her to become a biomedical engineer to help ease medical burdens and improve quality of life. She holds Bachelor’s and Master’s degrees in Biomedical Engineering from NC State University and University of New South Wales, respectively, a MBA from Duke University, and certifications as a Project Manager (PMP) and Clinical Trial Researcher (CCRP). Natasha has spent a good portion of her career in diabetes research and clinical trials for drug delivery devices. With 25 years’ experience in medical devices, today Natasha is a Director of Innovation at BD Technologies & Innovation (Durham, NC), leading a team developing new medical products to advance healthcare. She is involved with her local Breakthrough T1D NC Triangle chapter as a board member and their Clinical Trial Education Volunteer. She is excited about supporting such an amazing cause to help find a T1D cure and make T1D lives easier until then!
Meet Your CTEVs: Thomas Kern
Tom, a member of the Breakthrough T1D Piedmont Triad Board, was diagnosed with type 1 diabetes at age 8, 37 years ago. His dad was diagnosed in his mid-50s (originally, he was mis-diagnosed as a Type 2). Tom’s younger daughter, Jocelyn, was diagnosed at age 7 (via TrialNet, while she was still in Stage 2, before she needed insulin). Tom and his wife, Amy, got Jocelyn into a post-clinical trial of ATG, with Dr. Michael Haller at the University of Florida, more than six years ago and—although she wears a CGM—Jocelyn has still not progressed to Stage 3/insulin-dependence.